Osaka, Japan

Takao Tobe

This inventor holds 1 USPTO granted patent. Top assignee: Toray Industries, Inc.. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takao Tobe. Retrieved from https://idiyas.com/inventor/takao-tobe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Achievements of Inventor Takao Tobe in Retinal Health Innovations

Introduction

Takao Tobe, an accomplished inventor based in Osaka, Japan, has made significant contributions to the field of pharmaceuticals. With a focus on retinal health, his innovative work is paving the way for new treatments targeting various oculopathies.

Latest Patents

Takao Tobe holds a patent for a pharmaceutical composition designed to serve as a retinal pigment epithelial cell growth stimulating agent. This composition combines an interferon with a pharmaceutically acceptable carrier, providing a promising therapeutic solution for conditions such as pigmentary retinal degeneration, central chorioretinopathy, and macular dystrophy.

Career Highlights

Currently, Takao Tobe is associated with Toray Industries, Inc., where he continues to develop and refine pharmaceutical innovations. His expertise in retinal health and focused research efforts have positioned him as a key player in the medical research community.

Collaborations

Throughout his career, Takao has collaborated with notable colleagues, including Kanji Takahashi and Hiroshi Ohkuma. Their combined expertise contributes significantly to advancing research and development in the field of ophthalmology.

Conclusion

Takao Tobe’s innovative spirit and dedication to improving retinal health through his patent reflect the valuable contributions of inventors in the pharmaceutical industry. His work not only highlights the importance of addressing oculopathies but also reinforces the vital role that collaboration plays in scientific advancement.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…